日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Serum Bile Acid Elevation is an Independently Associated With Pruritus in Patients With At-risk Metabolic Dysfunction-associated Steatotic Liver Disease.

血清胆汁酸升高与有代谢功能障碍风险的脂肪肝患者的瘙痒症独立相关

期刊:Journal of Clinical and Experimental Hepatology
影响因子:3.2
doi:10.1016/j.jceh.2025.102549
Younossi Zobair M, Estep Michael J, Felix Sean, Lam Brian, Mukherjee Sumanta, Swift Brandon, Casillas Linda, de Souza Andrea R, Hunnicutt Jake, McLaughlin Megan M, Racila Andrei, Nader Fatema, Stepanova Maria
代谢
脂肪肝
发表日期：2025
文献求助 收藏

Analysis of C4 Concentrations to Predict Impact of Patient-Reported Diarrhea Associated With the Ileal Bile Acid Transporter Inhibitor Linerixibat

通过分析 C4 浓度预测患者报告的与回肠胆汁酸转运体抑制剂利奈昔巴相关的腹泻的影响

期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.13300
Carreño, Fernando; Mehta, Rashmi; de Souza, Andrea Ribeiro; Collins, Jon; Swift, Brandon
发表日期：2025
文献求助 收藏

Physiologically Based Biopharmaceutics Model (PBBM) of Minimally Absorbed Locally Acting Drugs in the Gastrointestinal Tract-Case Study: Tenapanor

基于生理的生物药剂学模型（PBBM）在胃肠道局部吸收极少的药物中的应用——以替那帕诺为例

期刊:Pharmaceutics
影响因子:5.5
doi:10.3390/pharmaceutics15122726
Stamatopoulos, Konstantinos; Mistry, Nena; Fotaki, Nikoletta; Turner, David B; Swift, Brandon
发表日期：2023
文献求助 收藏

Dose selection for a phase III study evaluating gepotidacin (GSK2140944) in the treatment of uncomplicated urogenital gonorrhoea

一项评估吉泊他辛（GSK2140944）治疗单纯性泌尿生殖道淋病的III期研究的剂量选择

期刊:Sexually Transmitted Infections
影响因子:2.9
doi:10.1136/sextrans-2022-055518
Scangarella-Oman, Nicole E; Hossain, Mohammad; Perry, Caroline R; Tiffany, Courtney; Powell, Marcy; Swift, Brandon; Dumont, Etienne F
微生物学
淋病
发表日期：2023
文献求助 收藏

Clinical assessment of gepotidacin (GSK2140944) as a victim and perpetrator of drug-drug interactions via CYP3A metabolism and transporters

通过 CYP3A 代谢和转运蛋白对吉泊他辛 (GSK2140944) 作为药物相互作用的受害者和施害者进行临床评估

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.13477
Barth, Aline; Perry, Caroline R; Shabbir, Shaila; Zamek-Gliszczynski, Maciej J; Thomas, Sebin; Dumont, Etienne F; Brimhall, Darin B; Nguyen, Dung; Srinivasan, Meenakshi; Swift, Brandon
代谢
发表日期：2023
文献求助 收藏

Design and Conduct Considerations for First-in-Human Trials

首次人体试验的设计和实施注意事项

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.12582
Shen, Jie; Swift, Brandon; Mamelok, Richard; Pine, Samuel; Sinclair, John; Attar, Mayssa
Human
发表日期：2019
文献求助 收藏

Innovation at the Intersection of Clinical Trials and Real-World Data Science to Advance Patient Care

临床试验与真实世界数据科学交叉领域的创新，旨在提升患者护理水平。

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.12559
Swift, Brandon; Jain, Lokesh; White, Craig; Chandrasekaran, Vasu; Bhandari, Aman; Hughes, Dyfrig A; Jadhav, Pravin R
发表日期：2018
文献求助 收藏

Impact of basolateral multidrug resistance-associated protein (Mrp) 3 and Mrp4 on the hepatobiliary disposition of fexofenadine in perfused mouse livers

基底外侧多药耐药相关蛋白（Mrp）3和Mrp4对灌注小鼠肝脏中非索非那定肝胆分布的影响

期刊:Drug Metabolism and Disposition
影响因子:4
doi:10.1124/dmd.107.019273
Tian, Xianbin; Swift, Brandon; Zamek-Gliszczynski, Maciej J; Belinsky, Martin G; Kruh, Gary D; Brouwer, Kim L R
发表日期：2008
文献求助 收藏